Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › NH › ROCHESTER › FRISBIE MEMORIAL HOSPITAL

FRISBIE MEMORIAL HOSPITAL

NPI: 1003858408 · ROCHESTER, NH 03867 · General Acute Care Hospital · NPI assigned 06/11/2006

$4.80M
Total Medicaid Paid
220,772
Total Claims
145,950
Beneficiaries
186
Codes Billed
2018-01
First Month
2020-05
Last Month

Provider Details

Authorized OfficialCAPLE, JOCELYN (PRESIDENT & CEO)
NPI Enumeration Date06/11/2006

Related Entities

Other providers sharing the same authorized official: CAPLE, JOCELYN

ProviderCityStateTotal Paid
FRISBIE MEMORIAL HOSPITAL ROCHESTER NH $1.24M
SALMON FALLS PATHOLOGY LLC ROCHESTER NH $8K
FRISBIE MEMORIAL HOSPITAL ROCHESTER NH $3K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 101,600 $1.98M
2019 101,751 $2.39M
2020 17,421 $433K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 15,560 9,788 $762K
99284 Emergency department visit for the evaluation and management, high severity 8,943 5,646 $735K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 2,662 1,675 $305K
99282 Emergency department visit for the evaluation and management, low to moderate severity 6,629 4,873 $252K
74177 Computed tomography, abdomen and pelvis; with contrast material 973 757 $244K
A0427 Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) 2,937 1,563 $194K
70450 Computed tomography, head or brain; without contrast material 1,155 854 $189K
71046 Radiologic examination, chest; 2 views 4,396 3,360 $151K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2,907 2,135 $119K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 16,345 8,412 $116K
97530 Therapeutic activities, direct patient contact, each 15 minutes 2,212 745 $106K
A0429 Ambulance service, basic life support, emergency transport (bls-emergency) 1,477 842 $101K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 3,454 977 $61K
74176 Computed tomography, abdomen and pelvis; without contrast material 284 222 $60K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1,688 948 $57K
80053 Comprehensive metabolic panel 11,417 8,049 $54K
76700 Ultrasound, abdominal, real time with image documentation; complete 593 483 $54K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1,641 743 $52K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 3,878 2,929 $47K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 11,501 8,140 $41K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 2,532 758 $41K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 446 396 $39K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 2,313 1,385 $36K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1,311 1,051 $36K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1,242 870 $34K
76830 Ultrasound, transvaginal 358 319 $34K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 603 188 $32K
96375 Therapeutic injection; each additional sequential IV push 2,204 1,428 $31K
84443 Thyroid stimulating hormone (TSH) 3,535 2,850 $30K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1,100 732 $26K
96361 Intravenous infusion, hydration; each additional hour 2,019 1,381 $26K
A0425 Ground mileage, per statute mile 4,637 2,407 $24K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 554 423 $22K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 235 187 $21K
90834 Psychotherapy, 45 minutes with patient 439 272 $21K
99000 8,647 6,759 $21K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 2,465 2,191 $21K
71275 Computed tomographic angiography, chest, with contrast material 81 63 $20K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 1,025 923 $19K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1,025 923 $19K
J7030 Infusion, normal saline solution , 1000 cc 3,351 1,971 $17K
80061 Lipid panel 1,896 1,663 $16K
73610 364 316 $16K
76801 183 148 $15K
73130 353 304 $15K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 502 391 $15K
71260 Computed tomography, thorax, diagnostic; with contrast material 108 79 $15K
73630 394 333 $15K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 110 88 $14K
88305 Level IV - Surgical pathology, gross and microscopic examination 737 528 $14K
71045 Radiologic examination, chest; single view 934 652 $14K
72125 Computed tomography, cervical spine; without contrast material 63 54 $14K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 557 496 $12K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 414 131 $12K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 634 555 $12K
76820 239 135 $10K
83036 Hemoglobin; glycosylated (A1C) 1,924 1,569 $10K
87086 Culture, bacterial; quantitative colony count, urine 2,672 2,113 $10K
87077 1,574 1,349 $10K
97597 234 87 $10K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 623 501 $9K
73030 228 172 $9K
71250 95 78 $8K
73110 246 212 $7K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 253 80 $7K
G0378 Hospital observation service, per hour 112 37 $7K
72100 182 156 $7K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 846 723 $7K
84484 2,114 1,235 $6K
87040 1,480 617 $6K
80048 Basic metabolic panel (calcium, ionized) 1,496 1,160 $6K
97162 248 185 $6K
84702 639 491 $6K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 35 26 $6K
73564 133 108 $6K
97535 Self-care/home management training, each 15 minutes 622 397 $5K
93971 63 54 $5K
76819 Fetal biophysical profile; without non-stress testing 57 24 $5K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 141 89 $5K
85027 1,786 1,179 $5K
87081 1,119 1,018 $5K
83690 1,439 1,070 $5K
82550 2,240 1,342 $5K
87186 1,003 799 $5K
86850 593 465 $5K
J2704 Injection, propofol, 10 mg 2,255 1,374 $4K
81001 2,678 2,062 $4K
83735 1,690 1,078 $4K
74018 178 122 $4K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 506 450 $4K
97161 254 187 $4K
82553 2,059 1,199 $4K
36415 Collection of venous blood by venipuncture 9,391 5,751 $4K
86803 395 338 $4K
96376 282 200 $3K
12001 55 28 $3K
86780 356 310 $3K
94060 66 51 $3K
83880 351 256 $3K
80050 General health panel 484 439 $3K
82607 383 332 $3K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 928 383 $3K
82728 413 324 $3K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 53 38 $3K
84439 450 386 $3K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 27 26 $3K
83605 583 383 $2K
85379 515 405 $2K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 239 161 $2K
J0690 Injection, cefazolin sodium, 500 mg 537 364 $2K
87340 337 277 $2K
86140 655 532 $2K
83550 452 361 $2K
85610 1,310 853 $2K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes 162 109 $2K
83540 535 424 $2K
J2405 Injection, ondansetron hydrochloride, per 1 mg 2,402 1,618 $2K
73140 49 40 $2K
86618 165 146 $1K
81025 378 315 $1K
87150 77 64 $1K
J1885 Injection, ketorolac tromethamine, per 15 mg 2,285 1,384 $1K
81003 1,257 1,037 $1K
J3010 Injection, fentanyl citrate, 0.1 mg 1,795 1,018 $1K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 74 55 $1K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 30 12 $1K
85652 701 575 $1K
85007 1,121 696 $1K
94729 50 39 $1K
82746 119 105 $1K
J0696 Injection, ceftriaxone sodium, per 250 mg 370 214 $1K
J2250 Injection, midazolam hydrochloride, per 1 mg 1,445 842 $835.82
87205 332 259 $811.05
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 111 71 $800.76
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,189 669 $782.99
82043 239 211 $773.53
82570 259 221 $755.12
76770 24 15 $722.52
86906 111 79 $602.13
J1170 Injection, hydromorphone, up to 4 mg 367 198 $565.36
87653 44 38 $564.37
80074 16 15 $496.59
73080 14 12 $479.27
97035 67 30 $476.50
J7050 Infusion, normal saline solution, 250 cc 272 114 $452.25
82784 51 45 $404.28
87140 100 92 $394.67
87808 33 30 $368.32
87905 37 32 $366.10
36416 708 402 $334.79
84100 292 141 $333.75
82948 537 300 $322.09
84403 14 13 $299.28
94726 13 12 $293.66
90715 49 39 $282.93
G0008 Administration of influenza virus vaccine 422 283 $244.52
J2270 Injection, morphine sulfate, up to 10 mg 241 149 $235.54
86038 31 27 $234.47
S9982 Medical records copying fee, per page 15 15 $228.00
J2060 Injection, lorazepam, 2 mg 370 231 $220.34
86762 20 17 $212.33
80076 42 29 $207.43
84146 16 14 $207.01
90662 117 80 $199.70
86900 111 79 $180.06
83655 15 13 $157.50
82950 46 40 $153.68
90686 251 186 $131.87
87210 65 56 $131.45
83516 15 13 $129.25
82565 63 40 $121.69
84481 13 12 $117.68
J0171 Injection, adrenalin, epinephrine, 0.1 mg 36 26 $80.72
85730 17 14 $77.66
J1200 Injection, diphenhydramine hcl, up to 50 mg 112 82 $71.43
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 15 15 $62.07
86431 14 13 $49.30
85378 15 12 $39.45
J1630 Injection, haloperidol, up to 5 mg 47 25 $38.55
84460 13 12 $36.80
84156 14 12 $32.07
J2550 Injection, promethazine hcl, up to 50 mg 20 12 $18.51
J1644 Injection, heparin sodium, per 1000 units 67 12 $12.43
A9270 Non-covered item or service 83 47 $7.52
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 133 89 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 98 67 $0.00